Site Logo

Download QR

Open Free Demat Account!

Join Our 9 Lakh Customers

+91
Headphone

Home

Mutual Funds

HDFC Pharma And Healthcare Fund

HD

HDFC Pharma And Healthcare Fund

Sectoral-PharmaRank #2
Not Rated

NAV (2026-07-14)

20.79

AUM

₹2,611.33 Cr

Exp. Ratio: 2.2%

RISK LEVEL

Very High

Returns & Performance

1 Year19.74%6.91% vs cat avgRank #1
3 Year----
5 Year----
Since Launch30.14%--

Fund vs Category Average

1Y
19.74%+6.91%

Pros & Cons

Pros

Outperforms category avg on 1Y returns
No lock-in period
Top-5 ranked in category for 1Y (#1)
Overall top-10 rank in category (#2)

Cons

3Y returns below category average
Higher expense ratio (2.2%)
ISININF179KC1HL7
NAV₹20.79
NAV Date2026-07-14
AUM₹2,611.33 Cr
Expense Ratio2.2%
RiskVery High
RatingNot Rated / 5
Min SIP Amount₹100
Max SIP Amount₹999999999
Min Additional Inv.₹100
SIP AllowedYes
Plan TypeRegular
Plan OptionGrowth
Is NFONo
Fund House Incorp.1999-12-10

INVESTMENT OBJECTIVE

The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

Exit Load1.00%
Stamp duty on investment0.005% (from July 1st, 2020)
Tax implicationsIf you redeem within one year, your returns will be taxed at 20%. For redemptions after one year, returns exceeding ₹1.25 lakh in a financial year will be taxed at 12.5%.

Dhruv Muchhal

Mr. Dhruv has done B.Com, CA and CFA

Prior to joining HDFC MF,he has worked with Motilal Oswal Financial Services Ltd., Goldman Sachs, CRISIL Global Research & Analytics and Deloitte Haskins & Sells

Top Holdings

Holdings data not available for this scheme